Skip to main content
Aequus Pharmaceuticals Inc. (TSXV: AQS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Jan 13, 2025, 1:53 PM EST

Aequus Pharmaceuticals Revenue

Aequus Pharmaceuticals had revenue of 148.32K CAD in the quarter ending September 30, 2024, with 1,010.26% growth. This brings the company's revenue in the last twelve months to 413.17K, down -29.63% year-over-year. In the year 2023, Aequus Pharmaceuticals had annual revenue of 254.90K, down -81.53%.

Revenue (ttm)
413.17K
Revenue Growth
-29.63%
P/S Ratio
1.61
Revenue / Employee
n/a
Employees
12
Market Cap
663.17K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023254.90K-1.12M-81.53%
Dec 31, 20221.38M-1.33M-49.17%
Dec 31, 20212.71M122.09K4.71%
Dec 31, 20202.59M960.09K58.81%
Dec 31, 20191.63M222.28K15.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Green Thumb Industries 1.51B
WELL Health Technologies 957.69M
dentalcorp Holdings 1.51B
Curaleaf Holdings 1.83B
Trulieve Cannabis 1.58B
Sienna Senior Living 867.55M
Cronos Group 150.26M
Extendicare 1.42B
Revenue Rankings

Aequus Pharmaceuticals News

More News